1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 363 F.Supp.3d
  5. 363 F.Supp.3d 1378 (2019)
 

IN RE VALSARTAN N-NITROSODIMETHYLAMINE (NDMA)

MDL No. 2875.

363 F.Supp.3d 1378 (2019)

IN RE: VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) CONTAMINATION PRODUCTS LIABILITY LITIGATION.

United States Judicial Panel on Multidistrict Litigation.

February 14, 2019.

TRANSFER ORDER

Before the Panel:* This litigation arises out of an investigation by the U.S. Food and Drug Administration into impurities found in generic drug products containing valsartan, a medication indicated for the treatment of high blood pressure and other conditions...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases